A novel plasmid-mediated PAC ß-lactamase (PAC-2) variant confers resistance to ceftazidime-avibactam in Klebsiella quasipneumoniae ST526 in Colombia
Open Access
- 17 November 2025
- journal article
- Published by Elsevier in Journal of Global Antimicrobial Resistance
- Vol. 46, 46-48
Abstract
No abstract availableAll Related Versions
Funding Information
- Instituto Nacional de Salud
This publication has 9 references indexed in Scilit:
- First report of KPC variants conferring ceftazidime-avibactam resistance in Colombia: introducing KPC-197Microbiology Spectrum, 2024
- Klebsiella pneumoniae carbapenemase variants: the new threat to global public healthClinical Microbiology Reviews, 2023
- First report of environmental bla PAC-1 -carrying Aeromonas enteropelogenesMicrobiology Spectrum, 2023
- Class C β-Lactamases: Molecular CharacteristicsClinical Microbiology Reviews, 2022
- Impact of Acquired Broad-Spectrum β-Lactamases on Susceptibility to Cefiderocol and Newly Developed β-Lactam/β-Lactamase Inhibitor Combinations in Escherichia coli and Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 2022
- Epidemiology and Mechanisms of Ceftazidime–Avibactam Resistance in Gram-Negative BacteriaEngineering, 2022
- Acquisition of Class C β-Lactamase PAC-1 by Sequence Type 644 Strains of Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 2019
- Extensively Drug-Resistant Pseudomonas aeruginosa ST309 Harboring Tandem Guiana Extended Spectrum β-Lactamase Enzymes: A Newly Emerging Threat in the United StatesOpen Forum Infectious Diseases, 2019
- Diversity, biology and evolution of IncQ-family plasmidsPlasmid, 2012